Company

World class team

Alvotech’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new biosimilar medicines quickly and safely to market.

Robert Wessman is the founder and chairman of Alvotech as well as the CEO for global generic pharmaceuticals company Alvogen. The experienced leadership team is lead by Mark Levick.

Mark Levick

Mark Levick

CEO of Alvotech

Joseph E. McClellan

Joseph E. McClellan

Chief Scientific Officer

Fausto Berti

Fausto Berti

SVP late stage development

Timo Liebig

Timo Liebig

SVP early stage development

Jayanth Sridhar

Jayanth Sridhar

COO

Sesselja Omarsdottir

Sesselja Omarsdottir

SVP analitycs

Kevin M. Bain

Kevin M. Bain

Chief financial officer

Founder & Chairman

Meet the Chairman

Robert Wessman founded Alvotech in 2013 with the mission to set a new standard in biosimilars. Wessman’s initial strategy was to invest in the development and manufacture of a portfolio of biosimilar monoclonal antibodies and to build a state-of-the-art manufacturing facility in Reykjavik Iceland.